Keratinocyte Collagenase-1 Expression Requires an Epidermal Growth Factor Receptor Autocrine Mechanism

• Published in: The Journal of biological chemistry 1999-04, Vol.274 (15), p.10372-10381
• Main Authors: Pilcher, B K, Dumin, J, Schwartz, M J, Mast, B A, Schultz, G S, Parks, W C, Welgus, H G
• Format: Article
• Language: English
• Subjects: Animals; Burns - enzymology; Cell Movement; Cells, Cultured; Collagenases - biosynthesis; Collagenases - genetics; Enzyme Inhibitors - pharmacology; Enzyme-Linked Immunosorbent Assay; ErbB Receptors - antagonists & inhibitors; ErbB Receptors - physiology; Humans; In Situ Hybridization; Keratinocytes - cytology; Keratinocytes - enzymology; Male; Matrix Metalloproteinase 1; Quinazolines - pharmacology; Swine; Transfection; Wound Healing
• ISSN: 0021-9258; 1083-351X
• DOI: 10.1074/jbc.274.15.10372

In response to cutaneous injury, expression of collagenase-1 is induced in keratinocytes via α 2 β 1 contact with native type I collagen, and enzyme activity is essential for cell migration over this substratum. However, the cellular mechanism(s) mediating integrin signaling remain poorly understood. We demonstrate here that treatment of keratinocytes cultured on type I collagen with epidermal growth factor receptor (EGFR) blocking antibodies or a specific receptor antagonist inhibited cell migration across type I collagen and the matrix-directed stimulation of collagenase-1 production. Additionally, stimulation of collagenase-1 expression by hepatocyte growth factor, transforming growth factor-β1, and interferon-γ was blocked by EGFR inhibitors, suggesting a required EGFR autocrine signaling step for enzyme expression. Collagenase-1 mRNA was not detectable in keratinocytes isolated immediately from normal skin, but increased progressively following 2 h of contact with collagen. In contrast, EGFR mRNA was expressed at high steady-state levels in keratinocytes isolated immediately from intact skin but was absent following 2 h cell contact with collagen, suggesting down-regulation following receptor activation. Indeed, tyrosine phosphorylation of the EGFR was evident as early as 10 min following cell contact with collagen. Treatment of keratinocytes cultured on collagen with EGFR antagonist or heparin-binding (HB)-EGF neutralizing antibodies dramatically inhibited the sustained expression (6–24 h) of collagenase-1 mRNA, whereas initial induction by collagen alone (2 h) was unaffected. Finally, expression of collagenase-1 in ex vivo wounded skin and re-epithelialization of partial thickness porcine burn wounds was blocked following treatment with EGFR inhibitors. These results demonstrate that keratinocyte contact with type I collagen is sufficient to induce collagenase-1 expression, whereas sustained enzyme production requires autocrine EGFR activation by HB-EGF as an obligatory intermediate step, thereby maintaining collagenase-1-dependent migration during the re-epithelialization of epidermal wounds.